Inhaled nitric oxide in moderate-to-severe COVID-19 acute respiratory distress syndrome: a retrospective cohort study

RT @journaleinstein: This retrospective cohort study evaluated the responsiveness of #COVID19 acute #respiratorydistresssyndrome patients t…

This retrospective cohort study evaluated the responsiveness of #COVID19 acute #respiratorydistresssyndrome patients to inhaled #nitricoxide as part of their standard therapy. Read more: https://t.co/zaNc38sCJN #SARSCoV2 #lengthofstay #criticalillness #I

"...inhaled nitric oxide rescue therapy in COVID-19 patients with moderate-to-severe [ARDS] is associated with an augmentation in oxygenation with no mortality benefits. Neither mechanical ventilation nor intensive care unit length of stay were altered...

9,371/ Brazil (est. current tobacco smoking age 15+ was 13.1% in 2020) Of 105 in ICU with Covid-19 ARDS, 11.4% were smokers (not specified if current or ever) https://t.co/USKqlmODNx